Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Tyler Sandow

3PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Apr 20, 2026
Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma.

|Jan 10, 2026
Understanding Current Trends and Advances in Transarterial Radioembolization Dosimetry.

Shamar Young, Kiyon Naser-Tavakolian, Abin Sajan

|Jul 29, 2024
Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy.

Kelley Núñez, Tyler Sandow, Juan Gimenez

Pageof 1

Frequent Collaborators

3 joint publications

Juan Gimenez

2 joint publications

Ari Cohen

2 joint publications

Paul Thevenot

1 joint publications

Kelley Núñez

1 joint publications

Mina Hibino

1 joint publications

Shamar Young

1 joint publications

Kiyon Naser-Tavakolian

1 joint publications

Abin Sajan

1 joint publications

Stephen Reis

1 joint publications

Gregory Woodhead

Frequent Collaborators

3 joint publications

Juan Gimenez

2 joint publications

Ari Cohen

2 joint publications

Paul Thevenot

1 joint publications

Kelley Núñez

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.7K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on : Sep 20, 2020

6.1K
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.7K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on : Sep 20, 2020

6.1K
See more related videos